National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the overarching strategic vision and operational execution of the organization. Overseeing the transition to a modernized brand, the Chief Executive Officer ensures alignment between internal resources and the mission to facilitate life-saving transplants. This leadership role involves managing complex stakeholder relationships and driving growth across North American and international markets. By optimizing organizational efficiency, Amy Ronneberg directly impacts the ability to connect patients with life-saving donors. Ronneberg secures long-term sustainability by fostering innovation in medical registry management and donor recruitment. The Chief Executive Officer maintains rigorous standards for operational excellence, ensuring the organization remains agile in a rapidly evolving healthcare landscape. Through decisive leadership, Ronneberg advances the core objective of providing equitable access to cellular therapy for every patient in need.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages the fiscal health and long-term economic strategy of the organization. Overseeing capital allocation and budgetary planning, the Chief Financial Officer ensures that financial resources support critical research and donor registry operations. This leadership role involves maintaining transparency with donors and partners while driving cost-effective solutions for complex medical logistics. By implementing robust financial controls, Katherine Heyerdahl directly impacts the scalability of the organization's life-saving programs. Heyerdahl secures the necessary funding to support global expansion and technological upgrades. The Chief Financial Officer collaborates with the executive team to align fiscal priorities with the broader mission of the organization. Through disciplined financial management, Heyerdahl ensures the organization remains a stable and reliable partner for patients, medical centers, and research institutions across the United States and beyond.

Chris Arevalos-Jimenez, the President & Co-Founder at National Marrow Donor Program, drives the foundational mission and long-term strategic partnerships of the organization. Overseeing external relations and community outreach, the President & Co-Founder ensures that the organization maintains strong ties with stakeholders and advocacy groups. This leadership role involves championing the cause of donor recruitment and expanding the reach of life-saving services. By fostering collaborative networks, Chris Arevalos-Jimenez directly impacts the growth of the donor registry. Arevalos-Jimenez secures the support of key partners to sustain the organization's ambitious future. The President & Co-Founder provides vision and continuity, ensuring that the core values of the organization remain central to all operations. Through dedicated advocacy and strategic networking, Arevalos-Jimenez strengthens the organization's position as a leader in the medical community, ensuring that patients receive the support necessary for successful treatment outcomes.

Erika Brandt, the President at National Marrow Donor Program, manages the operational execution of specific regional programs and service delivery models. Overseeing the implementation of donor engagement strategies, the President ensures that operational workflows remain efficient and patient-focused. This leadership role involves coordinating with internal departments to streamline the process of matching donors with patients in need. By optimizing service delivery, Erika Brandt directly impacts the speed and effectiveness of transplant coordination. Brandt secures the operational success of regional initiatives by fostering collaboration among staff and medical partners. The President monitors performance metrics to ensure that all programs meet the organization's high standards for quality and care. Through focused operational management, Brandt drives the success of key service areas, ensuring that the organization effectively meets the needs of patients and families across its broad operational footprint.

Komal Khoja, the President at National Marrow Donor Program, directs the strategic development of specialized donor recruitment and public awareness campaigns. Overseeing the expansion of the donor base, the President ensures that outreach efforts reach diverse populations to improve matching probabilities for all patients. This leadership role involves analyzing market trends and implementing innovative communication strategies to increase donor registration. By driving public engagement, Komal Khoja directly impacts the diversity and size of the registry. Khoja secures the necessary resources to support large-scale recruitment events and educational programs. The President collaborates with marketing and clinical teams to ensure that outreach messaging is accurate and impactful. Through strategic leadership, Khoja enhances the organization's visibility and effectiveness, ensuring that the registry remains a robust and inclusive resource for patients seeking life-saving cellular therapies.

Sydney Salamy, the Chapter President at National Marrow Donor Program, leads local community initiatives and grassroots donor recruitment efforts. Overseeing the coordination of volunteer networks and regional events, the Chapter President ensures that the organization's mission is effectively communicated at the local level. This leadership role involves mobilizing community members to participate in donor drives and educational workshops. By fostering local partnerships, Sydney Salamy directly impacts the growth of the registry within specific geographic areas. Salamy secures the commitment of volunteers and local organizations to support the broader national mission. The Chapter President provides essential feedback to the executive team regarding local needs and opportunities for improvement. Through dedicated community leadership, Salamy strengthens the organization's presence, ensuring that local efforts contribute significantly to the overall success of the national donor registry and patient support programs.

Rob Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, architects the digital infrastructure and cybersecurity framework essential for registry operations. Overseeing data integrity and system security, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer ensures that sensitive medical information remains protected while facilitating seamless donor matching. This leadership role involves integrating advanced technology solutions to improve the speed and accuracy of transplant coordination. By fortifying the digital perimeter, Rob Hanson directly impacts the reliability of the organization's global network. Hanson secures the technological foundation required for future innovation in cellular therapy. The Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer drives digital transformation initiatives that enhance operational efficiency. Through proactive security measures, Hanson maintains the trust of patients and medical partners worldwide.

Ron Leonhardt, the Chief People Officer at National Marrow Donor Program, directs human capital strategy and organizational culture initiatives. Overseeing talent acquisition, employee development, and performance management, the Chief People Officer ensures that the workforce remains aligned with the mission of saving lives. This leadership role involves cultivating an inclusive environment that attracts top-tier professionals dedicated to medical advancement. By optimizing internal engagement, Ron Leonhardt directly impacts the productivity and morale of the organization's diverse teams. Leonhardt secures the talent pipeline necessary to support complex operational demands across regional offices. The Chief People Officer collaborates with leadership to implement policies that promote professional growth and operational agility. Through strategic workforce planning, Leonhardt ensures the organization possesses the human expertise required to navigate the challenges of the modern healthcare sector and maintain high standards of service for patients and donors.

Dennis Confer, the Chief Medical Officer at National Marrow Donor Program, leads the clinical strategy and medical research initiatives that define the organization's impact. Overseeing the development of transplant protocols and medical standards, the Chief Medical Officer ensures that every procedure meets the highest safety and efficacy benchmarks. This leadership role involves guiding clinical research and collaborating with medical institutions to improve patient outcomes. By advancing medical knowledge, Dennis Confer directly impacts the success rates of marrow and stem cell transplants. Confer secures the scientific integrity of the organization's registry and clinical programs. The Chief Medical Officer provides expert guidance on complex medical cases and regulatory compliance. Through rigorous clinical oversight, Confer ensures that the organization remains at the forefront of cellular therapy, providing life-saving solutions to patients facing critical health challenges in diverse medical environments.